Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))

Raymond Niaura

doi:10.1001/jama.296.11.1355

Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))

Global Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1355
Number of pages	1
Journal	Journal of the American Medical Association
Volume	296
Issue number	11
DOIs	https://doi.org/10.1001/jama.296.11.1355
State	Published - Sep 20 2006

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.296.11.1355

Cite this

Niaura, R. (2006). Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63)). Journal of the American Medical Association, 296(11), 1355. https://doi.org/10.1001/jama.296.11.1355

Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63)). / Niaura, Raymond.
In: Journal of the American Medical Association, Vol. 296, No. 11, 20.09.2006, p. 1355.

Research output: Contribution to journal › Comment/debate › peer-review

Niaura, R 2006, 'Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))', Journal of the American Medical Association, vol. 296, no. 11, pp. 1355. https://doi.org/10.1001/jama.296.11.1355

@article{6d051e9e970b447a929bf01788698145,

title = "Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))",

author = "Raymond Niaura",

year = "2006",

month = sep,

day = "20",

doi = "10.1001/jama.296.11.1355",

language = "English (US)",

volume = "296",

pages = "1355",

journal = "Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Erratum

T2 - Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))

AU - Niaura, Raymond

PY - 2006/9/20

Y1 - 2006/9/20

UR - http://www.scopus.com/inward/record.url?scp=33748898469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748898469&partnerID=8YFLogxK

U2 - 10.1001/jama.296.11.1355

DO - 10.1001/jama.296.11.1355

M3 - Comment/debate

AN - SCOPUS:33748898469

SN - 0098-7484

VL - 296

SP - 1355

JO - Journal of the American Medical Association

JF - Journal of the American Medical Association

IS - 11

ER -

Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this